Crystal Tissues Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 07-07-2024
- Paid Up Capital ₹ 1.33 M
as on 07-07-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 07-07-2024
- Revenue 15.62%
(FY 2022)
- Profit -19.28%
(FY 2022)
- Ebitda -33.77%
(FY 2022)
- Net Worth 9.18%
(FY 2022)
- Total Assets 8.70%
(FY 2022)
About Crystal Tissues
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.33 M.
The company currently has active open charges totaling ₹2.00 Cr.
Agarwala Vasudha, Pratibha Agarwala, Hemant Jhunjhunwala, and One other member serve as directors at the Company.
- CIN/LLPIN
U22190WB2008PTC126075
- Company No.
126075
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Crystal Tissues?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Agarwala Vasudha  | Director | 11-Mar-2019 | Current |
| Pratibha Agarwala | Director | 13-Feb-2015 | Current |
| Hemant Jhunjhunwala | Director | 24-May-2008 | Current |
| Raghav Agarwala | Director | 24-May-2008 | Current |
Financial Performance and Corporate Structure Insights of Crystal Tissues.
Crystal Tissues Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.62% increase. The company also saw a substantial fall in profitability, with a 19.28% decrease in profit. The company's net worth moved up by a moderate rise of 9.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crystal Tissues?
In 2020, Crystal Tissues had a promoter holding of 74.32% and a public holding of 25.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Supreme Holdings & Hospitality (India) LimitedActive 42 years 8 monthsRaghav Agarwala is a mutual person
- Lloyds Mercantile Co Engg Pvt LtdActive 49 years 7 months
Hemant Jhunjhunwala and Raghav Agarwala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 15 Oct 2022 | ₹2.00 Cr | Open |
How Many Employees Work at Crystal Tissues?
Unlock and access historical data on people associated with Crystal Tissues, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crystal Tissues, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crystal Tissues's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
